3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Sarcoma
1
Head & Neck
1
Gynecologic
1
Genitourinary
1
Gastrointestinal
1
Dermatologic
1
Breast
1
Conditions
Neuroblastoma
8
Ganglioneuroblastoma
4
Triple Negative Breast Neoplasms
3
Melanoma
3
Lung Neoplasms
3
Carcinoma, Non-Small-Cell Lung
2
Adenoma, Islet Cell
2
Uterine Cervical Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Resectable Esophageal Cancer
1
Neoplasms
1
Neoplasm Metastasis
1
Multiple Myeloma
1
Locally Advanced Pancreatic Adenocarcinoma
1
Leukemia, Plasma Cell
1
Gliosarcoma
1
Glioblastoma
1
Endometrial Neoplasms
1
Carcinosarcoma
1
Carcinoma, Transitional Cell
1
Carcinoma, Renal Cell
1
Carcinoma, Merkel Cell
1
Carcinoma, Intraductal, Noninfiltrating
1
Carcinoma, Hepatocellular
1
Interventions
Specimen Handling
9
Magnetic Resonance Spectroscopy
6
Biopsy
6
pembrolizumab
3
X-Rays
3
Nivolumab
3
olaparib
2
durvalumab
2
ceralasertib
2
Paclitaxel
2
Immunoglobulin G
2
Carboplatin
2
trastuzumab deruxtecan
1
sargramostim
1
ribociclib
1
pelcitoclax
1
cobimetinib
1
cediranib
1
capivasertib
1
cabozantinib
1
atezolizumab
1
Tissue Banks
1
Taxes
1
TIC10 compound
1
Radiation
1
Phantoms, Imaging
1
Minimally Invasive Surgical Procedures
1
Ipilimumab
1
Indocyanine Green
1
Fulvestrant
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Carcinosarcoma
×
Colony-Stimulating Factors
×
1 year
×
Clear all
NCT05269381
2026-03-12
PNeoVCA
Mayo Clinic
Phase 1/2
Recruiting
132 enrolled